Journal of Medical Cases, ISSN 1923-4155 print, 1923-4163 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Med Cases and Elmer Press Inc
Journal website

Case Report

Volume 12, Number 5, May 2021, pages 190-194

The Role of a Medical Intermediate Care Unit in the Management of Budd-Chiari Syndrome: Case Series


Table 1. Characteristics of the Series Cases of Budd-Chiari Syndrome
Case NrAge of diagnoseEtiologyClinical presentationProgression to ALFPeak ALT (U/L)Peak INRPeak serum creatinine (mg/dL)Admission Child-Pugh scoreAdmission MELD-Na scoreAdmission Rotterdam scoreAdmission BCS TIPS PI scoreTherapeutic strategyOutcome
Nr: number; ALT: alanine aminotransferase; APS: antiphospholipid syndrome; ALI: acute liver injury; ALF: acute liver failure; AST: aspartate aminotransferase; INR: international normalized ratio; MELD-Na: model of end-stage liver disease-sodium; BCS TIPS PI score: Budd-Chiari syndrome- transjugular intra-hepatic portosystemic shunting prognostic index score.
118APSSubacute on chronicNo111.10.659Class I 0.7244.62Anticoagulation, antiaggregation, plasmapheresis, rituximabSurvived
229APSALINo1864.450.711026Class III 2.034.67Anticoagulation, stentSurvived
329Acute myeloid leukemiaALIYes37974.11.81128Class III 1.925.33NoneDeath
451Primary MyelofibrosisALIYes1311.954.61133Class III 1.827.16Anticoagulation, antiaggregation, cytoreductive therapyDeath
547InconclusiveALFYes1942.60.971128Class III 3.516.53Anticoagulation, antiaggregation, liver transplantationSurvived